Connie W Tsao1, Jayandra J Himali2, Alexa S Beiser2, Martin G Larson2, Charles DeCarli2, Ramachandran S Vasan2, Gary F Mitchell2, Sudha Seshadri2. 1. From the Department of Medicine (C.W.T.), Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA; Departments of Neurology (J.J.H., A.S.B., S.S.) and Medicine (R.S.V.), School of Medicine, Departments of Biostatistics (J.J.H., A.S.B.) and Epidemiology (R.S.V.), School of Public Health, and the Department of Mathematics and Statistics (M.G.L.), Boston University, Boston, MA; Department of Neurology and Center for Neuroscience and Division of Biostatistics (C.D.), Department of Public Health Sciences, School of Medicine, University of California, Davis, CA; The Framingham Heart Study (C.W.T., J.J.H., A.S.B., M.G.L., R.S.V., S.S.), Framingham, MA; and Cardiovascular Engineering Inc. (G.F.M.), Norwood, MA. ctsao1@bidmc.harvard.edu. 2. From the Department of Medicine (C.W.T.), Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA; Departments of Neurology (J.J.H., A.S.B., S.S.) and Medicine (R.S.V.), School of Medicine, Departments of Biostatistics (J.J.H., A.S.B.) and Epidemiology (R.S.V.), School of Public Health, and the Department of Mathematics and Statistics (M.G.L.), Boston University, Boston, MA; Department of Neurology and Center for Neuroscience and Division of Biostatistics (C.D.), Department of Public Health Sciences, School of Medicine, University of California, Davis, CA; The Framingham Heart Study (C.W.T., J.J.H., A.S.B., M.G.L., R.S.V., S.S.), Framingham, MA; and Cardiovascular Engineering Inc. (G.F.M.), Norwood, MA.
Abstract
OBJECTIVE: We tested whether abnormal arterial stiffness and blood pressure would be associated with progression of brain aging measured by brain MRI and neurocognitive testing. METHODS: Framingham Offspring Cohort participants (n = 1,223, 61 ± 9 years, 56% women) without previous stroke or dementia underwent applanation tonometry, brain MRI, and neurocognitive testing at examination 7 (1998-2001). Follow-up brain MRI and neurocognitive testing was performed at examination 8 (2005-2008, mean interval 6.4 ± 1.3 years). We related examination 7 inverse-transformed carotid-femoral pulse wave velocity (iCFPWV), central pulse pressure (CPP), and mean arterial pressure to changes in the following variables between examinations 7 and 8: total cerebral brain volume, white matter hyperintensity volume, and performance on executive function and abstraction tasks, the Trail Making Test, Parts B and A (ΔTrails B-A), and Similarities tests. RESULTS: Higher baseline iCFPWV and CPP were associated with greater progression of neurocognitive decline (iCFPWV and ΔTrails B-A association: SD unit change in outcome variable per SD change in tonometry variable [β] ± SE = 0.10 ± 0.04, p = 0.019; CPP and ΔSimilarities association: -0.08 ± 0.03, p = 0.013). Higher mean arterial pressure, but not iCFPWV or CPP, was associated with increase in white matter hyperintensity volume ([β ± SE] 0.07 ± 0.03, p = 0.017). No tonometry measures were associated with change in cerebral brain volume. CONCLUSIONS: In middle-aged and older adults without evidence of clinical stroke or dementia, elevated arterial stiffness and pressure pulsatility are associated with longitudinal progression of subclinical vascular brain injury and greater neurocognitive decline. Treatments to reduce arterial stiffness may potentially reduce the progression of neurovascular disease and cognitive decline.
OBJECTIVE: We tested whether abnormal arterial stiffness and blood pressure would be associated with progression of brain aging measured by brain MRI and neurocognitive testing. METHODS: Framingham Offspring Cohort participants (n = 1,223, 61 ± 9 years, 56% women) without previous stroke or dementia underwent applanation tonometry, brain MRI, and neurocognitive testing at examination 7 (1998-2001). Follow-up brain MRI and neurocognitive testing was performed at examination 8 (2005-2008, mean interval 6.4 ± 1.3 years). We related examination 7 inverse-transformed carotid-femoral pulse wave velocity (iCFPWV), central pulse pressure (CPP), and mean arterial pressure to changes in the following variables between examinations 7 and 8: total cerebral brain volume, white matter hyperintensity volume, and performance on executive function and abstraction tasks, the Trail Making Test, Parts B and A (ΔTrails B-A), and Similarities tests. RESULTS: Higher baseline iCFPWV and CPP were associated with greater progression of neurocognitive decline (iCFPWV and ΔTrails B-A association: SD unit change in outcome variable per SD change in tonometry variable [β] ± SE = 0.10 ± 0.04, p = 0.019; CPP and ΔSimilarities association: -0.08 ± 0.03, p = 0.013). Higher mean arterial pressure, but not iCFPWV or CPP, was associated with increase in white matter hyperintensity volume ([β ± SE] 0.07 ± 0.03, p = 0.017). No tonometry measures were associated with change in cerebral brain volume. CONCLUSIONS: In middle-aged and older adults without evidence of clinical stroke or dementia, elevated arterial stiffness and pressure pulsatility are associated with longitudinal progression of subclinical vascular brain injury and greater neurocognitive decline. Treatments to reduce arterial stiffness may potentially reduce the progression of neurovascular disease and cognitive decline.
Authors: Gary F Mitchell; Mark A van Buchem; Sigurdur Sigurdsson; John D Gotal; Maria K Jonsdottir; Ólafur Kjartansson; Melissa Garcia; Thor Aspelund; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer Journal: Brain Date: 2011-11 Impact factor: 13.501
Authors: Charles DeCarli; Claudia Kawas; John H Morrison; Patricia A Reuter-Lorenz; Reisa A Sperling; Clinton B Wright Journal: J Gerontol A Biol Sci Med Sci Date: 2012-05-08 Impact factor: 6.053
Authors: Matthew P Pase; Andrew Pipingas; Marni Kras; Karen Nolidin; Amy L Gibbs; Keith A Wesnes; Andrew B Scholey; Con Stough Journal: J Hypertens Date: 2010-08 Impact factor: 4.844
Authors: Nilay S Shah; Jean-Sébastien Vidal; Kamal Masaki; Helen Petrovitch; G Webster Ross; Cathy Tilley; Ronald B DeMattos; Russell P Tracy; Lon R White; Lenore J Launer Journal: Hypertension Date: 2012-03-05 Impact factor: 10.190
Authors: Gary F Mitchell; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Michael J Pencina; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin Journal: Circulation Date: 2010-01-18 Impact factor: 29.690
Authors: Léon H G Henskens; Abraham A Kroon; Robert J van Oostenbrugge; Ed H B M Gronenschild; Monique M J J Fuss-Lejeune; Paul A M Hofman; Jan Lodder; Peter W de Leeuw Journal: Hypertension Date: 2008-10-13 Impact factor: 10.190
Authors: Jessica L Fry; Leona Al Sayah; Robert M Weisbrod; Isabelle Van Roy; Xiang Weng; Richard A Cohen; Markus M Bachschmid; Francesca Seta Journal: Hypertension Date: 2016-07-18 Impact factor: 10.190
Authors: Antonio M Chiarelli; Mark A Fletcher; Chin Hong Tan; Kathy A Low; Edward L Maclin; Benjamin Zimmerman; Tania Kong; Alexander Gorsuch; Gabriele Gratton; Monica Fabiani Journal: Neuroimage Date: 2017-09-01 Impact factor: 6.556
Authors: Chendi Cui; Akira Sekikawa; Lewis H Kuller; Oscar L Lopez; Anne B Newman; Allison L Kuipers; Rachel H Mackey Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472